Alerts will be sent to your verified email
Verify EmailASHOKAMET
|
Ashoka Metcast
|
Ushdev International
|
Welcure Drugs&Pharma
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
4.05 % | 0.63 % | 45.81 % |
|
5yr average Equity Multiplier
|
1.65 | -0.04 | -0.38 |
|
5yr Average Asset Turnover Ratio
|
0.62 | 0.12 | 0.25 |
|
5yr Avg Net Profit Margin
|
7.17 % | -131.68 % | -80.17 % |
|
Price to Book
|
0.29 | 0.0 | 0.26 |
|
P/E
|
3.83 | 0.0 | 0.98 |
|
5yr Avg Cash Conversion Cycle
|
536.93 Days | 135.38 Days | 2364.01 Days |
|
Inventory Days
|
179.55 Days | 0.0 | 20.66 Days |
|
Days Receivable
|
245.5 Days | 135.38 Days | 1232.42 Days |
|
Days Payable
|
40.99 Days | 0.0 | 0.0 |
|
5yr Average Interest Coverage Ratio
|
4.22 | -145.66 | -2.67 |
|
5yr Avg ROCE
|
5.65 % | 0.55 % | -7.19 % |
|
5yr Avg Operating Profit Margin
|
7.71 % | -213.28 % | -81.01 % |
|
5 yr average Debt to Equity
|
0.42 | -0.79 | -0.35 |
|
5yr CAGR Net Profit
|
117.73 % | n/a | -2.01 % |
|
5yr Average Return on Assets
|
2.83 % | -14.56 % | -1.33 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
53.65 % | 40.7 % | 0.0 |
|
Share Pledged by Promoters
|
0.0 | 37.98 % | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Ashoka Metcast
|
Ushdev International
|
Welcure Drugs&Pharma
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
-
|
Product Wise Break-Up
|